Tripep: The ChronVac-C® Study Has Been Successfully Completed with Good Safety and Favorable...
Tripep: The ChronVac-C® Study Has Been Successfully Completed with Good Safety and Favorable Clinical Data News source: Business Wire All samples from the 12 patients with chronic Hepatitis C genotype 1 treated with Tripep’s...


